2015 Cancer Liaison Physician Report, CCMC Community Comprehensive Cancer Center
Welcome to this WVU Cancer Institute Camden Clark Comprehensive Cancer Center annual report. This publication provides a summary overview of our cancer services in 2015. We are pleased to make this information available.
Becoming part of WVU Medicine and WVU Cancer Institute is not only a new organization structure, but it contributes to our success. Cancer patients benefit from this integrated cancer delivery system with convenient access to physicians and cancer services.
The cancer committee’s main focus is to continue to improve cancer care in the community and to assist CCMC in maintaining its accreditation by the American College of Surgeon. The Commission on Cancer (CoC), a program of the American College of Surgeons (ACoS), recognizes cancer care programs for their commitment to providing comprehensive, high-quality, and multidisciplinary patient centered care. WVU Cancer Institute Camden Clark Comprehensive Cancer Center was re-accredited by CoC with commendations awarded for outstanding work for several standards in October 2015.
With the expertise of a multidisciplinary team of cancer specialists at our institution, an accurate diagnosis can be established and a customized treatment plan can be formulated based on evidence-based guidelines. We also provide access to clinical trials through WVU Cancer Institute where appropriate. The patients are closely monitored during treatment. The psychosocial support services, the survivorship services and the palliative care team all work in close collaboration with cancer patients and their families.
Our strength is in clinical excellence and patient-centered care. In August a Breast Navigator, a dedicated oncology nurse navigator was recruited to coordinate breast health and breast care. Another primary focus is to facilitate the Breast Center accreditation for our Cancer Center. For that purpose in September the Breast Program Leadership Team was formed.
As the Liaison Physician for the American College of Surgeon, I am monitoring and evaluating the patient outcomes and I compare our survival data to the national statistics with help of our tumor registrars. I report quarterly to the cancer committee the performance of our program using the National Cancer Data Base (NCDB). Transparent reporting of accurate, timely information about patient care and outcomes reflects CCMC’s culture of continuous improvement and may help referring physicians make informed decisions.
The most common newly diagnosed cancers in our patients continue to be lung (21%), breast (15%), colorectal (11%) and prostate cancer (11%). On the following pages you will find Dr.Galloway’s colon cancer study and Dr.Szarko’s update on prostate cancer grading and we present the overview of the number of patients seen in the major cancer sites at out facility based on 2014 statistical data.
We often see advanced disease presentations while we know that early diagnosis is the key to achieve the best outcomes. Therefore CCMC offers a multitude of screening services including digital mammograms, colonoscopy, PSA screening and low-dose computed tomography (LDCT) screening for lung cancer of high risk patients. We share a commitment in the “80 by 18” National Colorectal Cancer Roundtable Initiative in the belief that we can eliminate colorectal cancer as a major public health problem by increasing colorectal screening to 80% by 2018.
We appreciate your interest in our program and hope you find this information informative.
Gabor Altdorfer, MD
Liaison Physician, Commission on Cancer
WVU Cancer Institute,
Camden Clark Comprehensive Regional Cancer Center